Format

Send to

Choose Destination
Thromb Res. 2015 Feb;135(2):339-46. doi: 10.1016/j.thromres.2014.12.001. Epub 2014 Dec 5.

Prothrombin G20210A mutation is associated with recurrent pregnancy loss: a systematic review and meta-analysis update.

Author information

1
Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No. 18 Meishan Road, Hefei (230032), Anhui, China. Electronic address: gaohui201320132@sina.cn.
2
Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No. 18 Meishan Road, Hefei (230032), Anhui, China; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei (230032), China. Electronic address: fbtao@126.com.

Abstract

BACKGROUND:

Thrombophilia is reported to be a candidate etiology of recurrent pregnancy loss (RPL). No conclusive results on the association between prothrombin G20210A mutation and RPL have been reported.

METHODS:

We undertook a systematic review and meta-analysis of 37 case-control studies using a comprehensive electronic search on papers published by May 2014. We studied 5400 cases and 4640 controls to investigate the potential association between G20210A and RPL. In this review, we define RPL as more than 2 miscarriages.

RESULTS:

A significant association was found between G20210A and RPL, with a combined odds ratio (OR) of 1.81 (95% confidence interval [CI]: 1.26-2.60). However, the risks differed in the subgroup analyses, categorized by study sites, maternal age, and type of miscarriages. The pooled OR remained significant in European studies (OR: 1.80, 95% CI: 1.35-2.41), whereas in the Middle-Eastern studies, it was not significant (OR: 2.39, 95% CI: 0.96-5.92). The risk of RPL was significantly higher in women older than 29 years (OR: 1.91, 95% CI: 1.61-6.11), and a positive relationship was only observed between prothrombin G20210A mutation and fetal loss, but not embryonic loss. There was no evidence of publication bias in any of the analyses. The sensitivity analyses showed that the findings were quite stable.

CONCLUSION:

This meta-analysis suggests that the G20210A prothrombin mutation increases the risk of RPL (fetal loss, primary RPL, or secondary RPL), particularly in Europeans and women older than 29 years. We recommend further screening in more specific groups among women.

KEYWORDS:

G20210A; Meta-analysis; Polymorphism; Recurrent pregnancy loss; Thrombophilia

PMID:
25528068
DOI:
10.1016/j.thromres.2014.12.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center